{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:47:05Z","timestamp":1791416825290,"version":"4.3.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T00:00:00Z","timestamp":1235692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s12253-009-9153-1","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T16:51:42Z","timestamp":1235667102000},"page":"555-560","source":"Crossref","is-referenced-by-count":56,"title":["Prognostic Significance of Phosphatase of Regenerating Liver-3 Expression in Ovarian Cancer"],"prefix":"10.1007","volume":"15","author":[{"given":"Tingting","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchao","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,27]]},"reference":[{"key":"9153_CR1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351:2519\u20132529","journal-title":"N Engl J Med"},{"key":"9153_CR2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910420507","volume":"42","author":"VR Zurawski Jr","year":"1988","unstructured":"Zurawski VR Jr, Orjaseter H, Andersen A et al (1988) Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer 42:677\u2013680","journal-title":"Int J Cancer"},{"key":"9153_CR3","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1093\/clinchem\/32.11.2110","volume":"32","author":"W Mastropaolo","year":"1986","unstructured":"Mastropaolo W, Fernandez Z, Miller EL (1986) Pronounced increases in the concentration of an ovarian tumor marker, CA-125, in serum of a healthy subject during menstruation. Clin Chem 32:2110\u20132111","journal-title":"Clin Chem"},{"key":"9153_CR4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02470551","volume":"16","author":"K Takahashi","year":"1986","unstructured":"Takahashi K, Shibukawa T, Moriyama M (1986) Clinical usefulness and false-positive results of CA 125 as a tumor marker of ovarian cancer-a study on 674 patients. Jpn J Surg 16:305\u2013310","journal-title":"Jpn J Surg"},{"key":"9153_CR5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrd963","volume":"1","author":"M Lyon","year":"2002","unstructured":"Lyon M, Ducruet A, Wipf P, et al (2002) Dual-specificity phosphates as targets for antineoplastic agents. Nat Rev Drug Discov 1:961\u2013976","journal-title":"Nat Rev Drug Discov"},{"key":"9153_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/bbrc.1998.8291","volume":"244","author":"Q Zeng","year":"1998","unstructured":"Zeng Q, Hong W, Tan YH (1998) Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem Biophys Res Commun 244:421\u2013427","journal-title":"Biochem Biophys Res Commun"},{"key":"9153_CR7","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1128\/MCB.14.6.3752","volume":"14","author":"RH Diamond","year":"1994","unstructured":"Diamond RH, Cressman DE, Laz TM, et al (1994) PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol 14:3752\u20133762","journal-title":"Mol Cell Biol"},{"key":"9153_CR8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3835(03)00517-2","volume":"202","author":"SR Werner","year":"2003","unstructured":"Werner SR, Lee PA, DeCamp MW, et al (2003) Enhanced cell cycle progression and down regulation of p21(Cip1\/Waf1) by PRL tyrosine phosphatases. Cancer Lett 202:201\u2013211","journal-title":"Cancer Lett"},{"key":"9153_CR9","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1158\/1078-0432.CCR-04-2357","volume":"11","author":"F Polato","year":"2005","unstructured":"Polato F, Codegoni A, Fruscio R, et al (2005) PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res 11:6835\u20136839","journal-title":"Clin Cancer Res"},{"key":"9153_CR10","first-page":"2716","volume":"63","author":"Q Zeng","year":"2003","unstructured":"Zeng Q, Dong JM, Guo K, et al (2003) PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res 63:2716\u20132722","journal-title":"Cancer Res"},{"key":"9153_CR11","first-page":"23","volume":"23","author":"X Wu","year":"2004","unstructured":"Wu X, Zeng H, Zhang X (2004) Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 23:23\u201327","journal-title":"Am J Pathol"},{"key":"9153_CR12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4161\/cbt.3.10.1111","volume":"3","author":"K Guo","year":"2004","unstructured":"Guo K, Li J, Tang JP, et al (2004) Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels. Cancer Biol Ther 3:945\u2013951","journal-title":"Cancer Biol Ther"},{"key":"9153_CR13","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/1078-0432.CCR-04-1984","volume":"11","author":"J Li","year":"2005","unstructured":"Li J, Guo K, Koh VW, et al (2005) Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases. Clin Cancer Res 11:2195\u20132204","journal-title":"Clin Cancer Res"},{"key":"9153_CR14","doi-asserted-by":"crossref","unstructured":"Guo K, Li J, Tang JP, et al (2008) Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice. Cancer Biol Ther 7","DOI":"10.4161\/cbt.7.5.5764"},{"key":"9153_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/153685904322771999","volume":"23","author":"L Peng","year":"2004","unstructured":"Peng L, Li Y, Meng L, et al (2004) Preparation and characterization of monoclonal antibody against protein tyrosine phosphatase PRL-3. Hybrid Hybridomics 23:23\u201327","journal-title":"Hybrid Hybridomics"},{"key":"9153_CR16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00432-004-0563-x","volume":"130","author":"L Peng","year":"2004","unstructured":"Peng L, Ning J, Meng L, et al (2004b) The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. J Cancer Res Clin Oncol 130:521\u2013526","journal-title":"J Cancer Res Clin Oncol"},{"key":"9153_CR17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/annonc\/mdl159","volume":"17","author":"L Wang","year":"2006","unstructured":"Wang L, Peng L, Dong B, et al (2006) Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol 17:1517\u20131522","journal-title":"Ann Oncol"},{"key":"9153_CR18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00384-007-0303-1","volume":"22","author":"Y Wang","year":"2007","unstructured":"Wang Y, Li ZF, He J, et al (2007) Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Int J Colorectal Dis 22:1179\u20131184","journal-title":"Int J Colorectal Dis"},{"key":"9153_CR19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000078671","volume":"71","author":"UA Miskad","year":"2004","unstructured":"Miskad UA, Semba S, Kato H, Yokozaki H (2004) Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology 71:176\u2013184","journal-title":"Pathobiology"},{"key":"9153_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00428-006-0361-8","volume":"450","author":"UA Miskad","year":"2007","unstructured":"Miskad UA, Semba S, Kato H, et al (2007) High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Virchows Arch 450:303\u2013310","journal-title":"Virchows Arch"},{"key":"9153_CR21","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1158\/1535-7163.MCT-05-0248","volume":"4","author":"B Stephens","year":"2005","unstructured":"Stephens B, Han H, Gokhale V, et al (2005) PRL phosphatases as potential molecular targets in cancer. Mol Cancer Ther 4:1653\u20131661","journal-title":"Mol Cancer Ther"},{"key":"9153_CR22","first-page":"2890","volume":"62","author":"H Han","year":"2002","unstructured":"Han H, Bearss DJ, Browne LW, et al (2002) Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 62:2890\u20132896","journal-title":"Cancer Res"},{"key":"9153_CR23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1535-7163.MCT-07-0542","volume":"7","author":"B Stephens","year":"2008","unstructured":"Stephens B, Han H, Hostetter G, et al (2008) Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells. Mol Cancer Ther 7:202\u2013210","journal-title":"Mol Cancer Ther"},{"key":"9153_CR24","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1158\/1078-0432.CCR-04-0485","volume":"10","author":"H Kato","year":"2004","unstructured":"Kato H, Semba S, Miskad UA, et al (2004) High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res 10:7318\u20137328","journal-title":"Clin Cancer Res"},{"key":"9153_CR25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bjc.6603261","volume":"95","author":"I Radke","year":"2006","unstructured":"Radke I, Gotte M, Kersting C, et al (2006) Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br J Cancer 95:347\u2013354","journal-title":"Br J Cancer"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-009-9153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-009-9153-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-009-9153-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T05:17:28Z","timestamp":1589606248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-009-9153-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,27]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9153"],"URL":"https:\/\/doi.org\/10.1007\/s12253-009-9153-1","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,27]]}}}